Cargando…
The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer
High-risk human papilloma virus (HPV) is the leading cause of cervical cancer. HPV oncogenes are responsible for the development of malignancy, and the E6 oncoprotein that HPV expresses induces the degradation of tumour suppressor protein p53 (p53). This degradation leads to the upregulation of p16;...
Autores principales: | Stiasny, Annika, Freier, Christoph P., Kuhn, Christina, Schulze, Sandra, Mayr, Doris, Alexiou, Christoph, Janko, Christina, Wiest, Irmi, Dannecker, Christian, Jeschke, Udo, Kost, Bernd P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649573/ https://www.ncbi.nlm.nih.gov/pubmed/29085443 http://dx.doi.org/10.3892/ol.2017.6752 |
Ejemplares similares
-
Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer
por: Beyer, Susanne, et al.
Publicado: (2017) -
Genotoxicity of Superparamagnetic Iron Oxide Nanoparticles in Granulosa Cells
por: Pöttler, Marina, et al.
Publicado: (2015) -
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
por: Beilner, Daniel, et al.
Publicado: (2020) -
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
por: Vattai, Aurelia, et al.
Publicado: (2017) -
Nuclear receptor corepressor (NCoR) is a positive prognosticator for cervical cancer
por: Beilner, Daniel, et al.
Publicado: (2021)